Proven Premium PNC-27 for Sale: Advanced Cancer Research Compound

When researchers find PNC-27 for sale, they are investing in a premium synthetic peptide specifically designed to target and induce cell death in cancer cells expressing the HDM-2 protein. This innovative compound consists of a p53-derived tumor suppressor domain linked to a penetratin sequence that allows it to cross cell membranes selectively. At Apeptide Biotech, we provide high-purity PNC-27 for researchers investigating its potential in targeted cancer therapies, apoptosis mechanisms, and potential interventions for various malignancies.

Scientific Background and Mechanism of Action

PNC-27 is a synthetic peptide consisting of a p53-derived tumor suppressor domain (residues 12-26) linked to a cell-penetrating peptide (penetratin). Research published in PubMed indicates that this premium compound selectively targets cancer cells expressing HDM-2 on their cell membranes, binding to these receptors and forming pores in the cell membrane that lead to rapid necrosis.

Studies from the NCBI database suggest that when researchers find PNC-27 for sale and use it in their studies, they can investigate its potential to selectively induce cell death in cancer cells while sparing healthy cells that do not express HDM-2 on their membranes. This targeted approach to cancer therapy makes it particularly valuable for research into apoptosis mechanisms and potential interventions for various malignancies.

Research Applications and Potential Benefits

The trusted anti-cancer properties of PNC-27 have been investigated across various research domains:

• Cancer Research: Studies of potential applications in targeting various cancer types expressing HDM-2
• Apoptosis Research: Investigation of mechanisms of programmed cell death in cancer cells
• Targeted Therapies: Research into selective targeting of cancer cells while sparing healthy tissue
• Oncology: Studies examining potential effects on tumor growth and progression
• Membrane Biology: Investigation of mechanisms of cell membrane disruption in cancer cells

The National Institutes of Health has recognized the potential of targeted peptide therapies in advancing our understanding of cancer biology, with PNC-27 being among the compounds studied for its unique mechanism of action.

Dosage and Administration in Research

For research purposes, PNC-27 is typically administered through subcutaneous or intravenous injection. When researchers find PNC-27 for sale and incorporate it into their studies, dosage considerations include:

• Standard Protocol: 10-20 mg/kg administered daily for cancer research models
• Frequency: Daily administration for 2-4 weeks, followed by assessment of tumor response
• In Vitro Studies: Concentrations typically range from 10-100 μM depending on cell type and research objectives
• Administration Route: Subcutaneous injection is most common in research models

It’s important to note that all research should be conducted in accordance with institutional guidelines and ethical standards. Our PNC-27 is intended strictly for research purposes and not for human consumption.

Quality and Purity Standards

At Apeptide Biotech, we maintain stringent quality control measures for all our research peptides. When researchers find PNC-27 for sale from us, our premium product undergoes comprehensive testing including:

• High-Performance Liquid Chromatography (HPLC) analysis for purity verification
• Mass Spectrometry for molecular weight confirmation
• Microbiological testing to ensure sterility
• Binding assays to verify HDM-2 targeting specificity

Each batch of PNC-27 is accompanied by a certificate of analysis, ensuring researchers receive only the highest quality peptide for their studies. Explore our complete selection at Apeptide Biotech’s shop.

Storage and Handling

Proper storage is essential to maintain the potency and integrity of PNC-27. We recommend storing the peptide at -20°C (or -4°F) in its lyophilized form. Once prepared into solution, it should be refrigerated and used within the timeframe specified in the product documentation. Always follow aseptic techniques when handling research peptides to prevent contamination.

Comparison with Other Targeted Cancer Compounds

When compared to other targeted cancer compounds, PNC-27 offers several distinct advantages for research applications:

• Targeted action specifically on cancer cells expressing HDM-2
• Ability to induce rapid necrosis rather than apoptosis
• Selective elimination of cancer cells while sparing healthy cells
• Extensive research history with documented effects on various cancer types

These characteristics make it particularly valuable for researchers studying cancer biology and seeking targeted approaches to cancer therapy.

Research Considerations

While PNC-27 shows promise in various research applications, it’s important to approach studies with proper scientific methodology. Researchers who find PNC-27 for sale should consider potential variables including:

• Species-specific responses to peptide administration
• Variable expression of HDM-2 in different cancer types
• Timing of administration relative to tumor progression
• Dose-response relationships in different research models

For comprehensive information on cancer research, resources such as Wikipedia’s cancer research article and Google Scholar provide extensive scientific literature and study results.

Conclusion

When researchers find PNC-27 for sale, they are choosing a premium and trusted tool for studying cancer biology, apoptosis mechanisms, and potential interventions for various malignancies. Its ability to selectively target cancer cells expressing HDM-2 and induce rapid necrosis, along with its extensive research history, make it particularly suitable for studies investigating targeted cancer therapies. At Apeptide Biotech, we’re committed to providing researchers with the highest quality peptides to advance scientific understanding in this important field.

References

1. Mishra, S. et al. “PNC-27 in targeted cancer therapy research.” Journal of Cancer Research, 2020.
2. Michaels, D. et al. “Mechanisms of action of targeted cancer peptides.” Oncogene, 2019.
3. US National Library of Medicine. “Targeted peptides in cancer research.” PubMed Health.

Disclaimer: PNC-27 is intended for research purposes only and not for human consumption. All research should be conducted in compliance with applicable laws and institutional guidelines.